Monomorphic Ventricular Tachycardia Clinical Trial
Official title:
An Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients With St. Jude Medical Implantable Cardioverter Defibrillator (ICD) Systems or Cardiac Resynchronization Therapy Defibrillation (CRT-D) Systems.
The intent of this observational study is to understand the role of non-invasive programmed stimulation (NIPS) to induce substrate based MMVT (Monomorphic Ventricular Tachycardia) in patients receiving new St. Jude Medical Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy Defibrillation (CRT-D) systems.
Approximately 50 centers worldwide will participate in the study. Additional centers outside
the US may be considered, as necessary. The anticipated enrollment duration is 48-60 months.
This study provides a mechanism for sites to refer subjects for potential enrollment to the
Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction
of Ventricular Tachycardia (STAR-VT) Investigational Device Exemption (IDE) study
(ClinicalTrials.gov NCT02130765).
Patients receiving ICD or CRT-D device implant (or have received it within 30 days) may be
enrolled in the study.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02130765 -
Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia
|
N/A | |
| Active, not recruiting |
NCT04893317 -
Cryoablation for Monomorphic Ventricular Tachycardia (CryoCure-VT)
|
N/A | |
| Completed |
NCT03734562 -
Trial to Evaluate the Efficacy and Safety of Substrate Ablation of Monomorphic Ventricular Tachycardia
|
N/A | |
| Withdrawn |
NCT02216760 -
Using Ripple Mapping to Guide Substrate Ablation of Scar Related Ventricular Tachycardia.
|
N/A |